The effect of EBV on WIF1, NLK, and APC gene methylation and expression in gastric carcinoma and nasopharyngeal cancer. Issue 10 (6th July 2017)

• Record Type: Journal Article
• Authors: Zhao, Zhenzhen; Liu, Wen; Liu, Jincheng; Wang, Jiayi; Luo, Bing
• Is Part Of: Journal of medical virology. Volume 89:Issue 10(2017)
• Page Start: 1844
• Page End: 1851
• Publication Date: 2017-07-06
• Subjects: EBV -- GC -- methylation -- MicroRNA -- NPC; Virology -- Periodicals; 616
• DOI: 10.1002/jmv.24863
• Languages: English
• ISSNs: 0146-6615

Abstract

Abstract : Epstein‐Barr virus (EBV) is an important DNA tumor virus that is associated with approximately 10% of gastric carcinomas and 99% of nasopharyngeal cancers (NPC). DNA methylation and microRNAs (miRNAs) are the most studied epigenetic mechanisms that can prompt disease susceptibility. This study aimed to detect the effect of EBV on Wnt inhibitory factor 1 (WIF1), Nemo‐like kinase (NLK), and adenomatous polyposis coli (APC) gene methylation, and expression in gastric carcinoma and NPC. The WIF1, NLK, and APC gene mRNA expression levels were measured by real‐time quantitative RT‐PCR in four EBV‐positive cell lines and four EBV‐negative cell lines. Bisulfite genomic sequencing or methylation‐specific PCR was used to detect the methylation status of the WIF1, NLK, and APC promoters. All cell lines were treated with 5‐azacytidine (5‐aza‐dC), miR‐BART19‐3p mimics or an inhibitor, and analyzed by flow cytometry and MTT cell proliferation assays. The WIF1, NLK, and APC promoters were hypermethylated in all eight cell lines. 5‐Aza‐dC displayed a growth inhibitory effect on cells . After transfection with miR‐BART19‐3p mimics, the expression of WIF1, and APC decreased, and the cellular proliferation rate increased. After transfection with the miR‐BART19‐3p inhibitor, the expression levels were higher, and the cell growth was inhibited. In the NPC and GC cell lines, the promoters of WIF1, NLK, and APC are highly methylated, and the expression of these three genes is regulated by miR‐BART19‐3p. The activity of the Wnt pathway in EBV‐associated tumors may be enhanced by miR‐BART19‐3p.